Privium Fund Management B.V. Bio N Tech Se Transaction History
Privium Fund Management B.V.
- $469 Million
- Q2 2025
A detailed history of Privium Fund Management B.V. transactions in Bio N Tech Se stock. As of the latest transaction made, Privium Fund Management B.V. holds 10,987 shares of BNTX stock, worth $1.2 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
10,987Holding current value
$1.2 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
336Shares Held
40MCall Options Held
1.53MPut Options Held
1.43M-
Baillie Gifford & CO8.04MShares$878 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$462 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$437 Million0.35% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$207 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$197 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...